India Eyes 100% Yearly Pilot Drug Tests After Air India Incident

India's aviation watchdog, the Directorate General of Civil Aviation (DGCA), is seriously considering making annual random dope testing mandatory for all commercial pilots, a significant leap from the current 10% coverage. This potential regulatory overhaul comes hot on the heels of an Air India pilot testing positive for marijuana after an August 4, 2026, Phuket-Delhi flight experienced a sudden, alarming altitude drop, which injured 24 people. Civil Aviation Minister K Rammohan Naidu confirmed that discussions are underway to explore expanding testing to every pilot, every year, at random times. The current rules, established in 2022, only require random drug testing for at least 10% of flight crew and air traffic controllers annually. However, the recent Air India incident has intensified scrutiny, pushing the DGCA to review existing guidelines on psychoactive substances and potential disciplinary actions. While Air India has already initiated a one-time mandatory drug test for its 5,000 pilots, the Federation of Indian Pilots (FIP) has proposed a more gradual increase to 25% annual testing, alongside the introduction of oral-fluid testing as an additional screening method. Moving to 100% annual random testing would be a global first, presenting both immense safety benefits and considerable operational challenges for India's aviation sector, which employs over 12,000 commercial pilots. Minister Naidu stressed the need to balance enhanced flight safety with the practical impact on airline schedules, crew availability, and testing infrastructure, as the DGCA continues its consultations with all involved parties. The Aircraft Accident Investigation Bureau (AAIB) is still investigating the Air India incident, with its preliminary report expected soon.